OBJECTIVES This study aimed to evaluate the optimal risk assessment model (RAM) to
stratify the risk of venous thromboembolism (VTE) in hospitalized patients with cancer. We …

Background Oncology guidelines suggest using the Khorana score to select ambulatory
cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) …

Abstract Background Risk assessment models (RAMs) are relevant approaches to identify
cancer outpatients at high risk of venous thromboembolism (VTE). Among the proposed …

Background Venous thromboembolism is the leading cause of death in cancer patients,
second only to tumor progression. The Khorana score is recommended by clinical …

This study aimed to compare the predictive value of 2009 and 2013 version of Caprini risk
assessment models (RAM) for venous thromboembolism (VTE) in cancer patients by …

Essentials• The Khorana score is validated for risk of venous thromboembolism (VTE) in
cancer outpatients.• We conducted a multicenter analysis of medically hospitalized cancer …

Aims This meta-analysis was conducted to evaluate the validity of the Caprini venous
thromboembolism (VTE) risk assessment scale in predicting the risk of VTE in inpatients with …

Background: Guidelines suggest the use of the Khorana score to select patients with solid
cancer receiving chemotherapy for thromboprophylaxis to prevent venous thromboembolism …

Purpose This study aimed to develop and validate a specific risk-stratification nomogram
model for the prediction of venous thromboembolism (VTE) in hospitalized patients with lung …

We aimed to evaluate the performance of the Khorana score in predicting venous
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …